Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
Plus de filtres








Gamme d'année
1.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;52(4): e8006, 2019. tab, graf
Article de Anglais | LILACS | ID: biblio-1001515

RÉSUMÉ

The aim of the study was to evaluate the diagnostic accuracy of thromboelastometry for assessing rivaroxaban concentrations. The accuracy of thromboelastometry was compared with the high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) method, which is the gold standard for drug plasma monitoring (the reference standard). Forty-six clinically stable patients were treated with 10, 15, or 20 mg of rivaroxaban once daily (OD group) or 15 mg twice a day (BID group) (no particular indication for treatment). Patient samples were collected 2 h after the use of the medication (peak) and 2 h before the next dose (trough). The rivaroxaban plasma concentrations were determined via HPLC-MS/MS, and thromboelastometry was performed using a ROTEM® delta analyzer. There were significant prolongations in clotting time (CT) for the 10, 15, and 20 mg of rivaroxaban treatments in the OD groups. In the 15 mg BID group, the responses at the peak and trough times were similar. At the peak times, there was a positive correlation between the plasma concentration of rivaroxaban and CT (Spearman correlation rho=0.788, P<0.001) and clot formation time (rho=0.784, P<0.001), and a negative correlation for alpha angle (rho=−0.771, P<0.001), amplitude after 5 min (rho=−0.763, P<0.001), and amplitude after 10 min (rho=−0.680, P<0.001). The CT presented higher specificity and sensitivity using the cut-off determined by the receiver characteristics curve. ROTEM has potential as screening tool to measure possible bleeding risk associated with rivaroxaban plasma levels.


Sujet(s)
Humains , Mâle , Femelle , Adulte , Adulte d'âge moyen , Sujet âgé , Sujet âgé de 80 ans ou plus , Surveillance des médicaments/méthodes , Inhibiteurs du facteur Xa/sang , Rivaroxaban/sang , Hémorragie/prévention et contrôle , Thromboélastographie , Tests de coagulation sanguine , Chromatographie en phase liquide à haute performance , Spectrométrie de masse en tandem , Inhibiteurs du facteur Xa/administration et posologie , Rivaroxaban/administration et posologie , Exactitude des données
2.
Rev. ciênc. farm. básica apl ; Rev. ciênc. farm. básica apl;31(2)maio-ago. 2010.
Article de Anglais | LILACS | ID: lil-570150

RÉSUMÉ

Obteve-se uma galactomanana quimicamente sulfatada (LLS-2) a partir de polissacarídeo extraído de sementes de Leucaena leucocephala, a qual apresentou 15.2% de sulfato e grau de derivatização de 0,60, e, seu efeito antiviral sobre a replicação do vírus Herpes simplex tipo 1 (HSV-1) em células Vero foi avaliado pela metodologia de redução do número de unidades formadoras de placas. LLS-2 apresentou 93.7% de inibição da replicação viral à concentração de 2,5 ?g/ml, quando adicionado durante as etapas iniciais de replicação, com um índice de seletividade maior que 1.000, sugerindo que LLS-2 inibe a ligação de HSV-1 às células hospedeiras.


A galactomannan extracted from the seeds of Leucaena leucocephala was sulfated chemically, yielding a polymer (LLS-2) with 15.2% sulfate by weight (degree of sulfation 0.60), and its effect on the replication of Herpes simplex virus 1 (HSV-1) in Vero cells was investigated. When added during infection and early replication, LLS-2 showed 93.7% inhibition of HSV-1 replication at a concentration of 2.5 ?g/mL, according to the reduction in the number of viral plaques, and a selectivity index higher than 1,000, suggesting that it inhibits HSV-1 binding to the host cell.


Sujet(s)
Antiviraux , Herpèsvirus humain de type 1 , Techniques in vitro , Polyosides , Graines
3.
Genet. mol. res. (Online) ; Genet. mol. res. (Online);7(2): 371-378, 2008. tab, ilus
Article de Anglais | LILACS | ID: lil-641002

RÉSUMÉ

Diffuse infiltrating gliomas are the most common tumors of the central nervous system. Gliomas are classified by the WHO according to their histopathological and clinical characteristics into four classes: grade I (pilocytic astrocytoma), grade II (diffuse astrocytoma), grade III (anaplastic astrocytoma), and grade IV (glioblastoma multiforme). Several genes have already been correlated with astrocytomas, but many others are yet to be uncovered. By analyzing the public SAGE data from 21 patients, comprising low malignant grade astrocytomas and glioblastomas, we found COL6A1 to be differentially expressed, confirming this finding by real time RT-PCR in 66 surgical samples. To the best of our knowledge, COL6A1 has never been described in gliomas. The expression of this gene has significantly different means when normal glia is compared with low-grade astrocytomas (grades I and II) and high-grade astrocytomas (grades III and IV), with a tendency to be greater in higher grade samples, thus rendering it a powerful tumor marker.


Sujet(s)
Humains , Astrocytome/génétique , Collagène de type VI/génétique , Analyse de profil d'expression de gènes , Astrocytome/anatomopathologie , Régulation de l'expression des gènes tumoraux , RT-PCR , ARN tumoral
4.
Braz. j. infect. dis ; Braz. j. infect. dis;11(2): 300-301, Apr. 2007.
Article de Anglais | LILACS, SES-SP | ID: lil-454734

RÉSUMÉ

We reported a case of septicemia by Vibrio cholerae O1, in São Paulo, Brazil. A 70-year-old male patient, living in an urban area, entered the emergency service having sepsis, dying 12 hours later. Blood culture was positive for Vibrio cholerae O1. This is the first case of bacteremia by Vibrio cholerae O1 reported in South America.


Sujet(s)
Sujet âgé , Humains , Mâle , Bactériémie/microbiologie , Infections à Vibrio/microbiologie , Vibrio cholerae O1/isolement et purification , Réaction de polymérisation en chaîne , Infections à Vibrio/diagnostic , Vibrio cholerae O1/génétique
5.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;38(11): 1571-1574, Nov. 2005. ilus
Article de Anglais | LILACS | ID: lil-414710

RÉSUMÉ

Large-scale genome projects have generated a rapidly increasing number of DNA sequences. Therefore, development of computational methods to rapidly analyze these sequences is essential for progress in genomic research. Here we present an automatic annotation system for preliminary analysis of DNA sequences. The gene annotation tool (GATO) is a Bioinformatics pipeline designed to facilitate routine functional annotation and easy access to annotated genes. It was designed in view of the frequent need of genomic researchers to access data pertaining to a common set of genes. In the GATO system, annotation is generated by querying some of the Web-accessible resources and the information is stored in a local database, which keeps a record of all previous annotation results. GATO may be accessed from everywhere through the internet or may be run locally if a large number of sequences are going to be annotated. It is implemented in PHP and Perl and may be run on any suitable Web server. Usually, installation and application of annotation systems require experience and are time consuming, but GATO is simple and practical, allowing anyone with basic skills in informatics to access it without any special training. GATO can be downloaded at [http://mariwork.iq.usp.br/gato/]. Minimum computer free space required is 2 MB.


Sujet(s)
Humains , Analyse de séquence d'ADN/méthodes , Biologie informatique/instrumentation , Recherche biomédicale/instrumentation , Systèmes de gestion de bases de données/instrumentation , Analyse de séquence d'ADN/instrumentation , Bases de données génétiques , Laboratoires , Sites étiquetés par des séquences , Interface utilisateur
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE